Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]FAPI-74 PET Imaging for Cancer Detection
NCT06503146Phase 2Recruiting
- Sponsor
- National Cancer Institute
- Start
- Sep 2025
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of [18F]-FAPI-74 in pancreatic ductal adenocarcinoma (PDAC), cholangiocarcinoma (CCA), hepatocellular carcinoma (HCC), gastric cancer (GC), bladder cancer, sponsored by National Cancer Institute. Started Sep 2025; status: recruiting.
02
Drugs
[18F]-FAPI-74
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)cholangiocarcinoma (CCA)hepatocellular carcinoma (HCC)gastric cancer (GC)bladder cancer
Beyond the preview
Go deeper on NCT06503146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06503146.